Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 453 of 6351
-
Fat infusions could help preterm babies breathe easier and develop better
Disease control Recruiting nowThe purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE …
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New ALS drug targets genetic cause in early human trial
Disease control Recruiting nowThis study will examine what happens when patients with amyotrophic lateral sclerosis (ALS) are given an investigational medication (study drug) known as LTX-002. Specifically, the researchers will be looking at safety, tolerability (if someone has any side effects from the drug)…
Phase 1/2 • Sponsor: Leal Therapeutics, Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a common acid reflux drug protect Children's airways?
Disease control Recruiting nowLaryngomalacia is the most common congenital laryngeal anomaly in children and is frequently associated with aspiration. This randomized controlled study aims to assess the role of proton pump inhibitor (PPI) therapy in reducing the incidence of aspiration in pediatric patients w…
Sponsor: Minia University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can the heart repair its own valve? a new surgical approach
Disease control By invitation onlywe use part of the cardiac chambre for replacement of destroyed valve on right side of the heart
Sponsor: Zagazig University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New cocktail targets Hard-to-Treat leukemia
Disease control Recruiting nowThe goal of this clinical research study is to learn if the combination of ruxolitinib with cladribine and venetoclax can help to control the disease in patients with R/R T-PLL.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Engineered immune cells take on rare muscle disorders
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy, safety and tolerability of an autologous T-cells expressing a chimeric antigen receptor (CAR) directed to B-Cell maturation antigen (BCMA) in patients with autoantibody-mediated myositi…
Phase 2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a diabetes drug slow MS brain damage?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate if the study drug will reduce brain and retinal atrophy by reducing inflammation and subsequently slowing neurodegeneration in people with Multiple Sclerosis. The main outcome for the trial is change in normalized brain parenchymal v…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for HER2-Low breast cancer: experimental drug takes on market leader
Disease control Recruiting nowThe study is designed to compare the efficacy and safety of different dose groups of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in patients with HR-positive, HER2-low unresectable locally recurrent/metastatic breast cancer. It will also exploratively evaluate the pharmacokin…
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug duo aims to make inoperable sinus cancer removable
Disease control Recruiting nowThis prospective, multicenter clinical study aims to evaluate the efficacy and safety of neoadjuvant therapy with MRG003 (Becotatug vedotin) combined with epirubicin in patients with EGFR-positive, unresectable recurrent sinonasal adenoid cystic carcinoma (SNACC). The primary que…
Phase 2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Two-Drug combo may boost outcomes for High-Risk PAH patients
Disease control Recruiting nowPulmonary arterial hypertension (PAH) is a rare, progressive disease associated with poor prognosis, especially in patients with cardiovascular comorbidities. Current guidelines recommend initial combination therapy, but evidence is lacking for patients with significant comorbidi…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug targets Hard-to-Treat lung cancer mutation in major trial
Disease control Recruiting nowNon-small cell lung cancer (NSCLC) is the most common type of lung cancer. The first treatment is usually chemotherapy, given with another treatment that targets specific proteins on cancer cells. If the cancer gets worse, the next main treatment is usually a medicine called doce…
Phase 3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktail takes on bulky head and neck tumors
Disease control Not yet recruitingStudy Objectives 1. Primary Objective: The core aim of this study is to investigate whether the sequential approach of Spatially Fractionated Radiotherapy followed by 3 cycles of induction chemotherapy combined with Iparomlimab and Tuvonralimab, definitive chemoradiotherapy,…
Phase 2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Cord blood transplant offers hope for young blood cancer patients
Disease control Recruiting nowThe purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
MRI-Guided radiation shows promise for brain tumors in new trial
Disease control Not yet recruitingConventional image-guided techniques (such as cone-beam CT) have poor soft tissue contrast and unsatisfactory treatment outcomes. MRgART offers high-resolution imaging of brain tissue and, by acquiring daily MR images, successfully achieves real-time image monitoring, displaying …
Phase 3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New radiation approach aims to cut painful side effects in head and neck cancer
Symptom relief Recruiting nowA national, randomized, clinical trial (phase III) investigating radiotherapy with protons compared with photons for patients with squamous cell carcinoma of the head and neck area eligible for radiotherapy, either radical or postoperative, with curative intent. Comparative dose …
Phase 3 • Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
A Two-Pronged immune attack against HPV: could it prevent cervical cancer?
Disease control OngoingPersistent high-risk human papillomavirus infection is an important precursor of cervical cancer and related cervical lesions. This single-center, randomized, assessor-blinded, parallel-group controlled trial evaluates whether dual-modality immunotherapy consisting of an oral imm…
Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could stem cells beat standard care for arthritic knees?
Disease control Recruiting nowStromaForte injection for knee OA
Phase 2/3 • Sponsor: Cellcolabs Clinical SPV Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Brain implant adapts in real time to help ataxia patients move better
Disease control Recruiting nowThe goal of this clinical trial is to test the safety of placing Deep Brain Stimulators (DBS) in the cerebellum and using electrical stimulation of that part of the brain to treat symptoms related to the participants spinocerebellar ataxia. Five adults diagnosed with spinocerebel…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for head and neck cancer: smart drug targets tumors, boosts immune system
Disease control Recruiting nowThe BeeHive study is an investigator-initiated, single center, open-label phase II clinical trial that is designed to conduct a comprehensive multiomic biomarker evaluation across two single-arm cohorts to elucidate mechanisms of response and resistance in recurrent and/or metast…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to boost stem cell transplant success in tough lymphoma
Disease control Recruiting nowThis phase I/II trial studies the side effects and best dose of pralatrexate in combination with bendamustine and total-body irradiation (TBI) followed by a donor stem cell transplant in treating patients with T-cell non-Hodgkin lymphoma that has come back after a period of impro…
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC